An observational study in Cerebral Palsy, sponsored by Klaipėda University. Active, not recruiting at 1 site in Lithuania. Open to participants aged 3 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Klaipėda University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This observational study examines leg muscle activity during supported standing and heart rate in different body positions in children aged 3-16 years with cerebral palsy who receive palliative care and have severe limitations in movement (Gross Motor Function Classification System levels IV-V).
Heart rate is recorded while lying and sitting for all participants. Children who can undergo supported standing as part of their usual care also have heart rate and leg muscle activity recorded while standing. Small sensors placed on the skin measure muscle electrical activity. Standing duration and any signs of discomfort are documented.
The researchers do not assign standing as a treatment. The study records responses during routine care.
This single-center observational study is conducted in a pediatric palliative care department in Klaipeda, Lithuania. Measurements are scheduled at weekly intervals, in the morning before breakfast, with one body position assessed at each visit: lying at the first visit, sitting at the second visit, and supported standing at the third visit where clinically appropriate.
Heart rate is recorded using a Polar H10 sensor for 20 minutes in lying and 20 minutes in sitting. During supported standing, heart rate and surface electromyography are recorded for up to 20 minutes, depending on tolerance. Participants with contraindications to standing undergo lying and sitting measurements only.
Surface electromyography is recorded bilaterally from the rectus femoris, biceps femoris, gluteus maximus, and lateral head of the gastrocnemius using the Biometrics DataLINK system. Root mean square amplitude is calculated in microvolts over the entire recorded standing period, separately for each muscle and side.
Mean heart rate is calculated over the entire recording for each body position. Standing tolerance is documented through actual standing duration, time to the first observed sign of discomfort, and free-text notes describing the child's condition and reasons for early termination. If no discomfort occurs, this is documented as no discomfort observed during the session. No standardized tolerance scale is used.
Lying and sitting heart rate measurements are compared within participants. Comparisons involving standing are limited to participants with standing recordings. Muscle activity is assessed during standing only.
1,941 studies on the registry are indexed under Cerebral Palsy; 459 are open to participants now.
This study's planned enrollment of 6 is below the median of 63 across 474 observational studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →Klaipėda University is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children aged 3-16 years with cerebral palsy, GMFCS levels IV-V, receiving care in the palliative care department of Biudžetinė įstaiga Klaipėdos sutrikusio vystymosi kūdikių namai, Klaipeda, Lithuania. Participants may include children admitted for respite care or supportive treatment. Both children who can undergo supported standing and those assessed only in lying and sitting positions are eligible.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Eligibility for standing measurements:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Children aged 3-16 years with cerebral palsy, GMFCS levels IV-V, receiving palliative care. All participants undergo heart rate recording while lying and sitting. Participants who can undergo supported standing as part of routine care additionally undergo heart rate and surface electromyography recording during standing. Participants with contraindications to standing undergo lying and sitting measurements only.
Other: Routine Care Positioning
Lying, sitting, and, where clinically appropriate, supported standing provided as part of routine care. Positioning is not assigned by the investigators. Heart rate is recorded in each assessed position, and surface electromyography is recorded during supported standing only.
Lower-Limb Surface Electromyography RMS Amplitude During Supported Standing
Surface electromyography root mean square (RMS) amplitude, expressed in microvolts (µV), calculated over the entire recorded supported-standing period. Measurements are obtained bilaterally from the rectus femoris, biceps femoris, gluteus maximus, and lateral head of the gastrocnemius using the Biometrics DataLINK system. Values are reported separately for each muscle and side, without normalization. This outcome is assessed only in participants undergoing supported standing as part of routine care.
Time frame: During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit.
Mean Heart Rate in Different Body Positions
Mean heart rate, expressed in beats per minute, calculated over the entire recording in each position. All participants are assessed while lying and sitting. Participants able to undergo supported standing are additionally assessed while standing. Recordings are obtained using a Polar H10 sensor on separate days at weekly intervals, in the morning before breakfast.
Time frame: During 20-minute lying and sitting recordings and up to 20 minutes of supported standing, across approximately two weeks.
Duration of Supported Standing
Actual supported-standing duration, expressed in minutes, up to a planned maximum of 20 minutes. Assessed only in participants undergoing supported standing. Reasons for early termination are documented in free-text notes.
Time frame: During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit.
Time to First Observed Sign of Discomfort During Supported Standing
Time in minutes from the start of supported standing to the first observed sign of discomfort, such as crying, restlessness, or pain-related behavior, documented in observational notes. If no signs occur, this is recorded as no discomfort observed during the actual session; the session end is not treated as a discomfort event.
Time frame: During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit.
Plan to share: No — There is no plan to share individual participant data with other researchers.
Started Oct 2026 (actual). Primary completion is estimated for Jan 2028, 15 months after the start.
Of 216 non-industry observational studies under Cerebral Palsy, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 15 months is below that.
Counting every sponsor, half of 220 studies reached it within 21 months; a quarter within 8 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Klaipėda University